CD274 and chordoma: In their exploration, the study highlights instances of sicca/Sjögren’s syndrome triggered by PD-1/PD-L1 checkpoint inhibitors, providing crucial insights into the dynamic interplay between immunomodulation and treatment responses in chordomas [21].